Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mito Q
- Development stage
- Phase 1
- Lead developer
- Bion Therapeutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Mito Q is a nutritional supplement developed by Bion Therapeutics, formulated as an oral syrup containing a combination of coenzyme Q10 (ubidecarenone) and L-carnitine (levocarnitine). Coenzyme Q10 is an essential cofactor in the mitochondrial electron transport chain that facilitates ATP synthesis and acts as a potent lipid-soluble antioxidant. L-carnitine is an amino acid derivative that facilitates the transport of long-chain fatty acids across the inner mitochondrial membrane into the mitochondrial matrix for beta-oxidation and energy production. Together, these components work synergistically to support cellular energy production, reduce oxidative stress, and improve mitochondrial function. Mito Q is primarily used to manage nutritional deficiencies, support cardiovascular health, and address muscle weakness or fatigue.
- Brand names
- Mito QMito Q Sugar Free SyrupMito Q Syrup
- Other names
- coenzyme Q10 + L-carnitinecoenzyme Q10 + levocarnitineubidecarenone + L-carnitineubidecarenone + levocarnitine
02
Targets
CRAT (Carnitine O-acetyltransferase)SLC7A1 (Cationic amino acid transporter 1)ND1 (Mitochondrial electron transport chain complex I)SLC22A5 (Organic cation/carnitine transporter 2)SDH (Mitochondrial electron transport chain complex II)bc1 complex (Cytochrome bc1 complex (plasmodium))
Beyond the preview
Go deeper on Mito Q.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mito Q.